Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H D White

Showing results (61-70 of 301) with videos related to

Pageof 31
Sort By:
Heart (British Cardiac Society)|August 18, 2004
Practising what is preached: the MINAP studyO C Raffel, H D White,
Pharmacoeconomics|February 7, 1993
Pharmacoeconomic aspects of treatment of acute myocardial infarction with thrombolytic agentsK S Woo, H D White
The New Zealand Medical Journal|January 24, 1997
Comparing health expenditureJ M Neutze, H D White
Heart (British Cardiac Society)|November 16, 2002
Relation between blood pressure after an acute coronary event and subsequent cardiovascular riskC-K Wong, H D White
Current Cardiology Reports|September 12, 2000
Direct thrombin inhibitors as adjuncts to thrombolytic therapyJ K French, H D White
European Heart Journal|September 16, 2000
Smoking: back to the future - again?J K French, H D White
Heart (British Cardiac Society)|August 17, 2005
The declining prevalence of ST elevation myocardial infarction in patients presenting with acute coronary syndromesN S Kleiman, H D White
International Journal of Cardiology|May 1, 1983
Antianginal efficacy of perhexiline maleate in patients refractory to beta-adrenoreceptor blockadeH D White, J B Lowe
Lancet (London, England)|January 16, 1988
Therapeutic trials in coronary thrombosis should measure left ventricular function as primary end-point of treatmentR M Norris, H D White
Australian and New Zealand Journal of Medicine|August 1, 1986
Thrombolysis: an effective therapy in acute coronary thrombosisH D White, R M Norris
Pageof 31

Showing results (61-70 of 301) with videos related to

Sort By:
Pageof 31
Heart (British Cardiac Society)|August 18, 2004
Practising what is preached: the MINAP studyO C Raffel, H D White,
Pharmacoeconomics|February 7, 1993
Pharmacoeconomic aspects of treatment of acute myocardial infarction with thrombolytic agentsK S Woo, H D White
The New Zealand Medical Journal|January 24, 1997
Comparing health expenditureJ M Neutze, H D White
Heart (British Cardiac Society)|November 16, 2002
Relation between blood pressure after an acute coronary event and subsequent cardiovascular riskC-K Wong, H D White
Current Cardiology Reports|September 12, 2000
Direct thrombin inhibitors as adjuncts to thrombolytic therapyJ K French, H D White
European Heart Journal|September 16, 2000
Smoking: back to the future - again?J K French, H D White
Heart (British Cardiac Society)|August 17, 2005
The declining prevalence of ST elevation myocardial infarction in patients presenting with acute coronary syndromesN S Kleiman, H D White
International Journal of Cardiology|May 1, 1983
Antianginal efficacy of perhexiline maleate in patients refractory to beta-adrenoreceptor blockadeH D White, J B Lowe
Lancet (London, England)|January 16, 1988
Therapeutic trials in coronary thrombosis should measure left ventricular function as primary end-point of treatmentR M Norris, H D White
Australian and New Zealand Journal of Medicine|August 1, 1986
Thrombolysis: an effective therapy in acute coronary thrombosisH D White, R M Norris
Pageof 31